Clinical Trial Update: A Study of the Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia

View source ↗

Summary

This completed pediatric trial in Korea studied eltrombopag in combination with immunosuppressive therapy for treatment-naïve severe aplastic anemia, assessing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Promacta (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Aplastic Anemia | Status: COMPLETED